Scarica l'app Stockscreener
1.22
3.94%
-0.05
Celularity Inc Borsa (CELU) Ultime notizie
CelularityFinancial Details - Crunchbase
Buyback Watch: What is Celularity Inc Equity Warrants revenue forecast2026 Update & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn
NEXGEL discloses $15M upfront payment for Celularity portfolio By Investing.com - Investing.com India
Celularity inks $35m deal for longevity push - Longevity.Technology
NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart.com
NEXGEL discloses $15M upfront payment for Celularity portfolio - Investing.com
NEXGEL Announces $15 Million Acquisition of Regenerative Biomaterial Products from Celularity, Expected to Triple Revenue and Drive Profitability - Quiver Quantitative
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities - The Manila Times
Biomaterial deal aims to triple NEXGEL sales and turn profit - Stock Titan
Inside Celularity’s bet on NEXGEL to shake up wound care biomaterials - Stock Titan
Biotechnology company Celularity Inc. (NASDAQ: CELU) recently reaffirmed its strategic commercialization partnership with NEXGEL, INC. (NASDAQ: NXGL). - Bitget
Macro Review: Is Celularity Inc Equity Warrant a speculative investmentIndex Update & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Celularity licenses biomaterials portfolio for up to $35 million By Investing.com - Investing.com Canada
Celularity licenses biomaterials portfolio for up to $35 million - Investing.com Nigeria
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy - Investing News Network
Celularity Inc. Secures $35 Million Strategic License Deal and Strengthens Capital Position to Advance Longevity-Focused Strategy - marketscreener.com
NexGel Acquires Celularity Regenerative Biomaterials in Transformative Deal - TipRanks
Celularity Licenses Biomaterials Portfolio to NexGel Partner - TipRanks
NexGel to Acquire Celularity Biomaterials Assets and Exclusive License in Deal Up to $35 Million - TradingView
Deal to triple NEXGEL (NASDAQ: NXGL) revenue and add profits - Stock Titan
Celularity Sells and Licenses Biomaterials Portfolio to NexGel in Deal Worth Up to $35 Million - TradingView
Celularity (Nasdaq: CELU) monetizes biomaterials in $35M license, pivots to longevity - Stock Titan
Biotechnology company Celularity Inc. recently announced a significant personnel change. - Bitget
NEXGEL, Inc. to Acquire Regenerative Biomaterial Portfolio from Celularity, Anticipating Tripled Revenue and Immediate Profitability - Quiver Quantitative
Biotechnology company Celularity Inc. (NASDAQ: CELU) has recently reached a strategic licensing agreement totaling 35 million dollars. - Bitget
NEXGEL Signs Definitive Agreement to License and Acquire - GlobeNewswire
Celularity Inc. Announces Strategic Partnership to Commercialize Biomaterials Portfolio, Generating Up to $35 Million in Payments - Quiver Quantitative
EXCLUSIVE: NexGel To Acquire Regenerative Biomaterial Portfolio From Celularity, Expects To Triple Revenue - Benzinga
Celularity’s $35M license shifts focus to placental longevity therapies - Stock Titan
NexGel secures regenerative biomaterials portfolio from Celularity in landmark transaction - MSN
Celularity names John Sprague acting CFO following executive departure - Investing.com Nigeria
CELU SEC FilingsCelularity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Breakouts Watch: Is Celularity Inc a defensive stockPrice Action & Safe Entry Point Alerts - baoquankhu1.vn
Will Celularity Inc. stock reach all time highs in 2026Weekly Loss Report & Reliable Price Action Trade Plans - Naître et grandir
Take Profit: Is Celularity Inc Equity Warrant impacted by rising ratesJuly 2025 Price Swings & Stock Market Timing Techniques - baoquankhu1.vn
Aug Shorts: What is Celularity Inc Equity Warrants revenue forecastJuly 2025 PreEarnings & Risk Controlled Swing Alerts - baoquankhu1.vn
Celularity names John Sprague acting CFO following executive departure By Investing.com - Investing.com India
Joseph Dossantos, Acting CFO, Leaves Celularity On Feb 27, 2026SEC Filing - TradingView
Celularity Inc Announces Departure of Joseph Dossantos as Svp, Finance, Effective February 27, 2026 - marketscreener.com
CELU Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CELUW SEC FilingsCelularity Inc 10-K, 10-Q, 8-K Forms - Stock Titan
CELUW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Portfolio Update: Is Celularity Inc Equity Warrant forming higher highs and higher lows2025 Volatility Report & Safe Capital Allocation Plans - baoquankhu1.vn
Celularity receives $12.2 million from sale of tax credits - Investing.com Nigeria
CELU PE Ratio & Valuation, Is CELU Overvalued - Intellectia AI
Aug Outlook: What are the risks of holding Celularity IncWeekly Risk Report & Fast Gain Swing Alerts - baoquankhu1.vn
CELUWCelularity Inc Latest Stock News & Market Updates - Stock Titan
Guidance Update: How do insiders feel about Celularity IncWeekly Trade Summary & Real-Time Volume Spike Alerts - baoquankhu1.vn
Treasury Yields: Can Celularity Inc maintain sales growthMarket Activity Summary & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Earnings Beat: Should I buy Epsium Enterprise Limited stock nowWeekly Trade Review & Technical Buy Zone Confirmation - baoquankhu1.vn
Trend Review: Can Celularity Inc Equity Warrant keep up with sector leaders2025 Technical Patterns & Weekly High Conviction Ideas - baoquankhu1.vn
Risk Off: Is MiMedx Group Inc stock a smart retirement pickCPI Data & Precise Buy Zone Tips - baoquankhu1.vn
Valuation Update: How does VOXR perform in inflationary periodsTrade Signal Summary & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Market Fear: Is Celularity Inc stock risky to hold nowJuly 2025 Snapshot & Technical Pattern Based Buy Signals - baoquankhu1.vn
Breakout Watch: Can Celularity Inc maintain sales growthMarket Risk Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Trading Recap: Can Celularity Inc maintain sales growthTrade Entry Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Will Celularity Inc. Equity Warrant benefit from AI trendsWeekly Profit Analysis & Community Trade Idea Sharing Platform - mfd.ru
Will Celularity Inc. Equity Warrant stock recover after earningsPortfolio Gains Report & Smart Swing Trading Alerts - mfd.ru
Aug Ideas: Why is DAVA stock going down2025 Earnings Surprises & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Volume Recap: Can Celularity Inc stock outperform in a bear marketJuly 2025 Closing Moves & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Is Celularity Inc. Equity Warrant benefiting from interest rate changes2025 Performance Recap & Weekly Setup with High ROI Potential - mfd.ru
Market Review: Is Celularity Inc Equity Warrant backed by strong institutional buying2025 Big Picture & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Celularity (CELU) holder reports 0% ownership in new Schedule 13G/A - Stock Titan
Celularity receives $12.2 million from sale of tax credits By Investing.com - Investing.com South Africa
Celularity of Florham Park gets $12.2M from sale of New Jersey net operating losses - ROI-NJ
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):